NEW YORK, NY--(Marketwired - Jan 20, 2017) - Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer of the healthcare industry, is announcing that Dr. Liu Zhongzheng, the chief scientist and medical advisor of Biotech Precision Berhad has signed a collaboration agreement with SHOM. Dr. Liu Zhongzheng has many achievements under his belt that allows him to direct and help the company succeed.
Among his achievements are the Outstanding Research Award of the Canadian Society of Clinical Chemists, the Makoto Nagano Prize for Educational Achievement of the International Cardiovascular Society, and the SCBA Distinguished Scientist Award, and the Biotechnology Innovation Award in February 2006. In addition, he has published over 300 scientific papers and publications in Nature, NEJM, Science, JBC, Proc NAS, Circulation and other world-renowned top medical journals.
George Chang, Chief Executive Officer of SHOM, commented, "Dr. Liu Zhongzheng will help drive Southern Home Medical Inc. forward into greater heights. With his help, we can further innovate our products and better our services, resulting in better revenue and more sales opportunities."
About Biotech Precision Berhad:
Biotech Precision Berhad (BPB) delivers luxuriously affordable and effective individualized beauty, wellness and healthcare therapy by using scientifically proven products and techniques to clients with degenerative diseases. The ultimate goal for BPB is to make beauty, wellness and healthcare a priority in the life of each guest. BPB's greatest desire is that with each visit, guests will discover a healthier and radiant person within themselves.
About Southern Home Medical, Inc.: Southern Home Medical, Inc. is a Holding Company with a focus on servicing the needs of the Healthcare Industry. SHOM will continue to leverage the success of their businesses in order to expand sales opportunities in other locations throughout the country with health, medical and equipment needs.
This press release contains forward-looking statements related to Southern Home Medical, CES Technology Ltd., and KC Global Inc., and the potential benefits of the acquisition, including statements regarding timing of closing and results of the proposed transaction. Actual events or results may differ materially from those contained in the forward-looking statements due to risks, uncertainties and assumptions. These risks and uncertainties include, but are not limited to, risks associated with: Southern Home Medical's ability to successfully integrate CES Technology Ltd.; execution of plans and strategies; the inability to successfully complete the transaction, and other important factors that could cause results of the acquisition and related transactions to differ materially from the forward-looking statements detailed in Southern Home Medical's public filings with OTC Markets and the SEC, including its most recent Annual Report. Southern Home Medical disclaims any obligation to update any forward-looking or other statements in this release, except as required by law.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 relating to Southern Home Medical operations, results of operations and other matters that are based on SHOM's current expectations, estimates, forecasts and projections. Words, such as "anticipate," "believe," "could," "expect," "estimate," "intend," "may," "opportunity," "plan," "positioned," "potential," "project," "should," and "will" and similar expressions, are intended to identify these forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Readers are cautioned not to put undue reliance on forward-looking statements.